◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial
6sources
6articles
4velocity
+0%since first seen
20d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (6)
- Pfizer's Mixed Phase III Data for Sigvotatug Vedotin in NSCLC Yahoo Finance · 21d ago
- Can Pfizer (NYSE:PFE) Clear Its Latest Oncology Hurdle? Kalkine Media · 21d ago
- Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial CancerNetwork · 21d ago
- Pfizer drug acquired in Seagen deal disappoints in lung cancer study BioPharma Dive · 21d ago
- Sigvotatug Vedotin Fails to Improve OS in Advanced, Pretreated Nonsquamous NSCLC OncLive · 21d ago
- Pfizer's $43B Seagen bet sours further as ADC fails in late-stage lung cancer trial Endpoints News · 21d ago
Related trends
▲ Peaking
Business
Stock Market Today: Bank Earnings Roll In; Goldman Sachs in Focus
Goldman Sachs reports record-breaking Q2 2026 earnings driven by a surge in equities trading activity.
▲ Peaking
Business
Expansive vision for Meridian skeleton building site: ‘let’s go to downtown Meridian tonight’
Developers have unveiled an expansive mixed-use vision for the skeleton building site at the former Union 93 location in downtown Meridian.
▲ Peaking
Business
The world no longer has an oil problem. It has a gasoline problem
▲ Peaking
Business
Exclusive: Google DeepMind's Demis Hassabis calls for U.S.-led global AI watchdog
Google DeepMind's Demis Hassabis is advocating for a U.S.-led global watchdog to test frontier AI models and ensure AGI safety.
▲ Peaking
Business
China’s trade surges in first half of 2026, extending growth streak
▲ Peaking
Business
World Cup's biggest spenders show up late as semifinals drive host city travel boom
Last-minute bookings from high-spending World Cup visitors are triggering a travel boom in host cities as the tournament enters its semifinals.